Status:

RECRUITING

To Describe How Well Vinorelbine Given Orally Works in Patients With a Breast Cancer After 2 Years of Treatment

Lead Sponsor:

Pierre Fabre Medicament

Conditions:

Advanced Breast Cancer

Eligibility:

FEMALE

18+ years

Brief Summary

This study looks at how well oral vinorelbine works in treating advanced breast cancer. It looks at women who have already had this treatment or are currently having it.

Detailed Description

This is an international, multicenter, retrospective and prospective, observational study. The study will comprise of two cohorts: * Retrospective: Patients who started OV treatment for ABC between ...

Eligibility Criteria

Inclusion

  • Female aged ≥ 18 years (≥ 19 years for Algeria as per local regulation) at oral vinorelbine ( OV) -based treatment initiation
  • Confirmed diagnosis of locally advanced or metastatic breast cancer eligible for chemotherapy
  • Initiated OV-based treatment as per SmPC for advanced breast cancer between January 2011 and December 2020 for the retrospective cohort or, initiating oral vinorelbine treatment at enrollment for the prospective cohort
  • Willing and able to complete the QoL questionnaire, PPQ and WPAI questionnaire for the prospective cohort
  • Provision of informed consent or non-opposition to the patient (or next of kin/legal representative, if applicable) for the use of data, according to local regulations

Exclusion

  • no exclusion criteria for patients in this study

Key Trial Info

Start Date :

September 10 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

February 1 2028

Estimated Enrollment :

368 Patients enrolled

Trial Details

Trial ID

NCT06500494

Start Date

September 10 2024

End Date

February 1 2028

Last Update

July 24 2025

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Centre Hospitalo-Universitaire Mustapha, Hopital Mustapha, Place du 1er Mai 1945, Sidi M'Hamed

Algiers, Algeria, 16000

2

Tianjing Medical University Cancer Institute & Hospital

Tianjin, Tianjin Municipality, China, 360060

3

Azienda Ospedaliera San Gerardo U.O. Oncologia Medica

Monza, Italy, 20052